Partial restoration of gut‐mucosal dysbiosis in late‐treated HIV‐infected subjects with CD4 T‐cell recovery
| Published in: | Clinical and Translational Medicine |
|---|---|
| Main Authors: | Israel Olivas‐Martínez, Isaac Rosado‐Sánchez, Juan Antonio Cordero‐Varela, Salvador Sobrino, Miguel Genebat, Inés Herrero‐Fernández, Rocío Martínez dePablos, Ana Eloísa Carvajal, Rocío Ruiz, Ana Isabel Álvarez‐Ríos, María Fontillón‐Alberdi, Ángel Bulnes‐Ramos, Vanesa Garrido‐Rodríguez, María del Mar Pozo‐Balado, Manuel Leal, Yolanda María Pacheco |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-04-01
|
| Online Access: | https://doi.org/10.1002/ctm2.788 |
Similar Items
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection
by: Isaac Rosado-Sánchez, et al.
Published: (2023-12-01)
by: Isaac Rosado-Sánchez, et al.
Published: (2023-12-01)
Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
by: Zhenzhan Zhang, et al.
Published: (2022-01-01)
by: Zhenzhan Zhang, et al.
Published: (2022-01-01)
Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.
by: Martinna Bertolini, et al.
Published: (2019-04-01)
by: Martinna Bertolini, et al.
Published: (2019-04-01)
Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers
by: Ziyang Min, et al.
Published: (2023-02-01)
by: Ziyang Min, et al.
Published: (2023-02-01)
The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function
by: Vanesa Garrido-Rodríguez, et al.
Published: (2024-12-01)
by: Vanesa Garrido-Rodríguez, et al.
Published: (2024-12-01)
Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients
by: Zhaoyi Pan, et al.
Published: (2023-01-01)
by: Zhaoyi Pan, et al.
Published: (2023-01-01)
Gut dysbiosis promotes the breakdown of oral tolerance mediated through dysfunction of mucosal dendritic cells
by: Tomohiro Fukaya, et al.
Published: (2023-05-01)
by: Tomohiro Fukaya, et al.
Published: (2023-05-01)
Dysbiosis and interactions of the mycobiome and bacteriome in mucosal lesions of erosive and non-erosive oral lichen planus patients
by: Liang Beibei, et al.
Published: (2024-12-01)
by: Liang Beibei, et al.
Published: (2024-12-01)
Aeromonas hydrophila Induces Skin Disturbance through Mucosal Microbiota Dysbiosis in Striped Catfish (Pangasianodon hypophthalmus)
by: Li-Hsuan Chen, et al.
Published: (2022-08-01)
by: Li-Hsuan Chen, et al.
Published: (2022-08-01)
Intestinal Microbiota Dysbiosis Disrupts the Mucosal Barrier, Triggering Inflammatory Responses in Gut-Kidney Interaction and Exacerbating Diarrhea
by: Shen J, et al.
Published: (2025-07-01)
by: Shen J, et al.
Published: (2025-07-01)
Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model
by: Guillaume Sarrabayrouse, et al.
Published: (2025-01-01)
by: Guillaume Sarrabayrouse, et al.
Published: (2025-01-01)
Effect of Adjunctive Use of Probiotics in the Treatment of Peri-Implant Mucositis: A Systematic Review and Meta-Analysis
by: Kelly Rocio Vargas Villafuerte, et al.
Published: (2023-10-01)
by: Kelly Rocio Vargas Villafuerte, et al.
Published: (2023-10-01)
Association of Gut Dysbiosis with Disease Phenotype and Treatment in Systemic Lupus Erythematosus
by: Irene Medina-Martínez, et al.
Published: (2025-08-01)
by: Irene Medina-Martínez, et al.
Published: (2025-08-01)
Effects of Antibiotic Residues on Fish Gut Microbiome Dysbiosis and Mucosal Barrier-Related Pathogen Susceptibility in Zebrafish Experimental Model
by: Jun Hyeok Yang, et al.
Published: (2024-01-01)
by: Jun Hyeok Yang, et al.
Published: (2024-01-01)
Diarrhea accompanies intestinal inflammation and intestinal mucosal microbiota dysbiosis during fatigue combined with a high-fat diet
by: Jing Liu, et al.
Published: (2023-05-01)
by: Jing Liu, et al.
Published: (2023-05-01)
Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients
by: Ángel Bulnes-Ramos, et al.
Published: (2023-02-01)
by: Ángel Bulnes-Ramos, et al.
Published: (2023-02-01)
Hyposalivation but not Sjögren’s syndrome associated with microbial dysbiosis in women
by: Carlos Saúco, et al.
Published: (2023-10-01)
by: Carlos Saúco, et al.
Published: (2023-10-01)
Combined BPA and DIBP Exposure Induced Intestinal Mucosal Barrier Impairment Through the Notch Pathway and Gut Microbiota Dysbiosis in Mice
by: Mengge Duan, et al.
Published: (2025-01-01)
by: Mengge Duan, et al.
Published: (2025-01-01)
Bladder Mucosal CO2 Compared with Gastric Mucosal CO2 as a Marker for Low Perfusion States in Septic Shock
by: Gemma Seller-Pérez, et al.
Published: (2012-01-01)
by: Gemma Seller-Pérez, et al.
Published: (2012-01-01)
The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma
by: Junying Lu, et al.
Published: (2017-01-01)
by: Junying Lu, et al.
Published: (2017-01-01)
Creating a Rat Model of Chronic Variate Stress
by: Rocío de Pablos, et al.
Published: (2014-12-01)
by: Rocío de Pablos, et al.
Published: (2014-12-01)
Association between oral dysbiosis and Parkinson’s disease: a systematic review
by: Laura Murcia-Flores, et al.
Published: (2025-05-01)
by: Laura Murcia-Flores, et al.
Published: (2025-05-01)
Esophageal microbial dysbiosis impairs mucosal barrier integrity via toll-like receptor 2 pathway in patients with gastroesophageal reflux symptoms
by: Songfeng Chen, et al.
Published: (2024-12-01)
by: Songfeng Chen, et al.
Published: (2024-12-01)
Oro-Respiratory Dysbiosis and Its Modulatory Effect on Lung Mucosal Toxicity during Exposure or Co-Exposure to Carbon Nanotubes and Cigarette Smoke
by: Brijesh Yadav, et al.
Published: (2024-02-01)
by: Brijesh Yadav, et al.
Published: (2024-02-01)
Microbiota dysbiosis impact on the metabolism of T3 and T4 hormones and its association with thyroid cancer
by: Santiago Cadena-Ullauri, et al.
Published: (2025-06-01)
by: Santiago Cadena-Ullauri, et al.
Published: (2025-06-01)
Microbiota Dysbiosis: A Key Modulator in Preeclampsia Pathogenesis and Its Therapeutic Potential
by: Johnatan Torres-Torres, et al.
Published: (2025-01-01)
by: Johnatan Torres-Torres, et al.
Published: (2025-01-01)
Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris
by: Maria J. E. Visser, et al.
Published: (2019-02-01)
by: Maria J. E. Visser, et al.
Published: (2019-02-01)
Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis
by: Patricia Ruiz-Limón, et al.
Published: (2025-01-01)
by: Patricia Ruiz-Limón, et al.
Published: (2025-01-01)
Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions
by: Mara Ioana Iesanu, et al.
Published: (2022-11-01)
by: Mara Ioana Iesanu, et al.
Published: (2022-11-01)
Preventive Photobiomodulation for Chemotherapy-Induced Oral Mucositis: A Systematic Review of Randomized Clinical Trials
by: Susell Parra-Rojas, et al.
Published: (2025-01-01)
by: Susell Parra-Rojas, et al.
Published: (2025-01-01)
Innovación y trabajo colaborativo en la enseñanza de las Ciencias Naturales: una experiencia didáctica sobre los dilemas éticos del proyecto genoma humano
by: Carolina Martínez, et al.
Published: (2009-02-01)
by: Carolina Martínez, et al.
Published: (2009-02-01)
Editorial: Microbial dysbiosis and immune dysregulation in periodontitis and peri-implantitis
by: Ana Carolina Morandini, et al.
Published: (2025-06-01)
by: Ana Carolina Morandini, et al.
Published: (2025-06-01)
Permeation Protection by Waterproofing Mucosal Membranes
by: Luisa Coderch, et al.
Published: (2023-11-01)
by: Luisa Coderch, et al.
Published: (2023-11-01)
Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease
by: Illyane S. Lima, et al.
Published: (2023-03-01)
by: Illyane S. Lima, et al.
Published: (2023-03-01)
Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.
by: Cynthia Maeto, et al.
Published: (2014-01-01)
by: Cynthia Maeto, et al.
Published: (2014-01-01)
Voice disorders in mucosal leishmaniasis.
by: Ana Cristina Nunes Ruas, et al.
Published: (2014-01-01)
by: Ana Cristina Nunes Ruas, et al.
Published: (2014-01-01)
Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
by: Felipe Francisco Tuon, et al.
Published: (2018-11-01)
by: Felipe Francisco Tuon, et al.
Published: (2018-11-01)
Dysbiosis and extraintestinal cancers
by: Ruishan He, et al.
Published: (2025-02-01)
by: Ruishan He, et al.
Published: (2025-02-01)
Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)
by: Marta Monticolo, et al.
Published: (2023-04-01)
Microbial dysbiosis in periodontitis
by: Sameera G Nath, et al.
Published: (2013-01-01)
by: Sameera G Nath, et al.
Published: (2013-01-01)
Similar Items
-
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection
by: Isaac Rosado-Sánchez, et al.
Published: (2023-12-01) -
Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
by: Zhenzhan Zhang, et al.
Published: (2022-01-01) -
Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection.
by: Martinna Bertolini, et al.
Published: (2019-04-01) -
Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers
by: Ziyang Min, et al.
Published: (2023-02-01) -
The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function
by: Vanesa Garrido-Rodríguez, et al.
Published: (2024-12-01)
